Astrana Health ASTH Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 10.7%-0.1pp | 10.7%+0.5pp | 10.3%-1.0pp | 11.3%-0.6pp | 11.9%-1.4pp | |
| Operating margin | 2.5%0.0pp | 2.5%+0.4pp | 2.1%-0.8pp | 2.9%-0.6pp | 3.5%-0.8pp | |
| Returns | ||||||
| Return on invested capital | 4.6%+0.5pp | 4.1%+1.4pp | 2.7%-1.8pp | 4.6%-1.1pp | 5.7%-1.6pp | |
| Efficiency | ||||||
| Asset turnover | 1.9×+0.1× | 1.8×+0.1× | 1.6×-0.2× | 1.8×0.0× | 1.8×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.3×-0.1× | 1.4×0.0× | 1.4×-0.2× | 1.6×-0.1× | 1.7×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 1.3×-0.1× | 1.4×0.0× | 1.4×+0.8× | 0.6×0.0× | 0.6×-0.1× | |
| Net debt / EBITDA | 4.2×-1.1× | 5.2×-1.1× | 6.4×+5.3× | 1.1×-0.7× | 1.8×+0.2× | |
| Valuation | ||||||
| Market capitalization | $1.36B+9.6% | $1.24B-4.9% | $1.31B+6.2% | $1.23B-12.4% | $1.41B-2.3% | |
| Price / sales | 0.4×0.0× | 0.4×-0.1× | 0.5×-0.1× | 0.5×-0.1× | 0.6×-0.1× | |
| Price / book | 1.7×+0.1× | 1.6×-0.1× | 1.7×+0.1× | 1.6×-0.3× | 1.9×-0.1× | |
| EV / EBITDA | 13.8×-1.4× | 15.2×-4.4× | 19.7×+6.2× | 13.5×-1.1× | 14.6×+0.8× | |
| Dividend yield | 0.2%-0.4pp | 0.6%0.0pp | 0.6%0.0pp | 0.7%0.0pp | 0.7%+0.4pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Astrana Health's profit margins?
- Astrana Health (ASTH) runs a 10.7% gross margin and a 2.5% operating margin, with a 0.9% net margin.
- Where do Astrana Health's ratios come from?
- Every ratio is computed from Astrana Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.